The differences between batch processing and continuous manufacturing of biologics require a detailed understanding of material traceability and the effects of perturbations on material quality.

New capability captures production signals, converts them into training-ready data, and gates releases on real-world distributions so model improvements compound over time. Most teams building ...

The benefits of continuous biologics manufacturing are generally accepted, but transitioning to continuous processing from batch processing is hindered by the lack of modeling and simulation tools.

A pair of researchers at OpenAI has published a paper describing a new type of model — specifically, a new type of continuous-time consistency model (sCM) — that increases the speed at which ...